1. Home
  2. IVR vs AUTL Comparison

IVR vs AUTL Comparison

Compare IVR & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo INVESCO MORTGAGE CAPITAL INC

IVR

INVESCO MORTGAGE CAPITAL INC

N/A

Current Price

$5.69

Market Cap

703.0M

Sector

Real Estate

ML Signal

N/A

Logo Autolus Therapeutics plc

AUTL

Autolus Therapeutics plc

N/A

Current Price

$1.80

Market Cap

596.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IVR
AUTL
Founded
2008
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
703.0M
596.2M
IPO Year
2008
2025

Fundamental Metrics

Financial Performance
Metric
IVR
AUTL
Price
$5.69
$1.80
Analyst Decision
Hold
Strong Buy
Analyst Count
6
9
Target Price
$8.17
★ $8.73
AVG Volume (30 Days)
★ 3.3M
1.4M
Earning Date
10-29-2026
11-11-2026
Dividend Yield
★ 25.35%
N/A
EPS Growth
★ 103.08
N/A
EPS
★ 0.10
N/A
Revenue
N/A
★ $10,120,000.00
Revenue This Year
$88.36
$98.68
Revenue Next Year
$8.03
$28.47
P/E Ratio
$56.80
★ N/A
Revenue Growth
N/A
★ 496.00
52 Week Low
$5.52
$1.18
52 Week High
$9.50
$2.58

Technical Indicators

Market Signals
Indicator
IVR
AUTL
Relative Strength Index (RSI) 20.31 41.14
Support Level N/A $1.37
Resistance Level $8.24 $1.92
Average True Range (ATR) 0.15 0.09
MACD -0.03 -0.01
Stochastic Oscillator 14.54 22.22

Price Performance

Historical Comparison
IVR
AUTL

About IVR INVESCO MORTGAGE CAPITAL INC

Invesco Mortgage Capital Inc is a REIT that invests, finances, and manages residential and commercial mortgage-backed securities and mortgage loans. The company's portfolio consists of residential mortgage-backed securities (RMBS) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association, or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation; Commercial mortgage-backed securities (CMBS) that are not guaranteed by a U.S. government agency or a federally chartered corporation; RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation; and other real estate-related financing arrangements.

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.

Share on Social Networks: